Related Experiment Video

Updated: Dec 9, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K

Dietary intake of magnesium in a type 1 diabetic pediatric population

Yasmine Benslama1, Nouria Dennouni-Medjati1, Majda Dali-Sahi1

  • 1Abou Bekr Belkaid University of Tlemcen, Department of Biology, Analytical Chemistry and Electrochemistry laboratory, 13000 Tlemcen, Algeria.

Magnesium Research
|September 9, 2020
PubMed

Insights

Type 1 diabetes in Algerian children is linked to low dietary magnesium intake. Addressing this deficiency through improved eating habits is crucial for managing the condition.

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Science
  • Diabetes Management

Background:

  • Adequate magnesium intake is recognized for its role in preventing diabetes and its complications.
  • Low magnesium levels have been observed in various chronic conditions, necessitating further investigation in pediatric diabetes.

Purpose of the Study:

  • To assess the daily dietary magnesium intake among Algerian children diagnosed with type 1 diabetes.
  • To explore the relationship between magnesium consumption and glycemic control in this pediatric population.

Main Methods:

  • A case-control study involving 96 children with type 1 diabetes and 105 healthy controls (ages 3-17).
  • Dietary magnesium intake was quantified using the 24-hour dietary recall method.
  • Statistical analyses included correlation, multinomial logistic regression, and odds ratio calculations.

Main Results:

  • A significantly higher prevalence of low magnesium intake was observed in diabetic children (84%) compared to controls (61%, P=0.001).
  • No significant correlation was found between magnesium intake and glycemic markers (glycemia, HbA1c).
  • Low daily dietary magnesium intake, below European Food Safety Authority (EFSA) recommendations, was associated with an increased odds ratio of 5.50 (P=0.002) for type 1 diabetes.

Conclusions:

  • Children with type 1 diabetes in western Algeria exhibit a high prevalence of inadequate dietary magnesium intake.
  • Interventions focused on modifying dietary habits are essential to correct low magnesium intake in this vulnerable pediatric group.
  • Improving magnesium consumption may be a key strategy in managing type 1 diabetes in children.

Keywords:
dietary intakemagnesiumpediatric populationtype 1 diabeteswestern Algeria

More Related Videos

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

868
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

5.2K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
531
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.6K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
245
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
763
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.8K